Serial Number:
97306650
Mark:
NALMEFENE HCL
Status:
Second Extension-Granted
Status Date:
03-12-2024
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists
Mark Description:
The mark consists of the words Nalmefene HCl beneath 5 small squares and three horizontal lines that transition from solid to decreasing shading.
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
01-17-2023
Owner:
Mark Drawing Status:
Design plus Words, Letters, and/or Numbers
Abandon Date:
N/A
Business Name:
DORSEY & WHITNEY LLP
Correspondent Name:
